Declassification of intelligence and additional transparency measures relating to the COVID–19 pandemic

Not later than 180 days after the date of the enactment of this Act, the Director of National Intelligence shall, in coordination with the heads of such Federal agencies as the Director considers appropriate— (1) perform a declassification review of intelligence relating to research conducted at the Wuhan Institute of Virology or any other medical or scientific research center within the People’s Republic of China, on coronaviruses, including— (A) information relating to Gain of Function research and the intention of this research; (B) information relating to sources of funding or direction for research on coronaviruses, including both sources within the People’s Republic of China and foreign sources; and (C) the names of researchers who conducted research into coronaviruses, as well as their current locations of employment; (2) perform a declassification review of intelligence relating to efforts by government officials of entities of the People’s Republic of China— (A) to disrupt or obstruct information sharing or investigations into the origins of the coronavirus disease 2019 (COVID–19) pandemic; (B) to disrupt the sharing of medically significant information relating to the transmissibility and potential harm of SARS–CoV–2 to humans, including— (i) efforts to limit the sharing of information with the United States Government; (ii) efforts to limit the sharing of information with the governments of allies and partners of the United States; and (iii) efforts to limit the sharing of information with the United Nations and World Health Organization; (C) to obstruct or otherwise limit the sharing of information between national, provincial, and city governments within the People’s Republic of China and between subnational entities within the People's Republic of China and external researchers; (D) to deny the sharing of information with the United States, allies and partners of the United States, or multilateral organizations, including the United Nations and the World Health Organization; (E) to pressure or lobby foreign governments, journalists, medical researchers, officials of the United States Government, or officials of multilateral organizations (including the United Nations and the World Health Organization) with respect to the source, scientific origins, transmissibility, or other attributes of the SARS–CoV–2 virus or the COVID–19 pandemic; (F) to disrupt government or private-sector efforts to conduct research and development of medical interventions or countermeasures for the COVID–19 pandemic, including vaccines; and (G) to promote alternative narratives regarding the origins of COVID–19 as well as the domestic Chinese and international response to the COVID–19 pandemic; (3) provide for public release a declassified report that contains all appropriate information described under paragraphs (1) and (2) and which includes only such redactions as the Director determines necessary to protect sources and methods and information of United States persons; and (4) submit to the congressional intelligence committees an unredacted version of the declassified report required under paragraph (3).